VQ5-17889-45553
1 vaccination
2 coded responses
15 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 954 / CA
- Registered
- 2021-07-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-03
Dose 1 — Janssen/Johnson & Johnson
-
2021-07-04
Registered in v-safe
-
2021-07-04
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-07-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-07-06
- 2021-07-07
- 2021-07-08
- 2021-07-09
- 2021-07-10
- 2021-07-17
-
2021-07-24
Survey response — day 21, single doseMedDRA: Headache — Feeling: GoodFree text: HeadacheMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-07-31
- 2021-08-09
- 2021-08-14
- 2021-10-02
-
2022-01-03
Survey response — 6 months, dose 1MedDRA: Headache — Feeling: GoodFree text: HeadachesMedDRA releases: 2024-11 · check-in free text available
- 2022-07-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-03 | Janssen/Johnson & Johnson | No |
Free text
Release 9 — day 21, single dose
Symptoms: Headache
Release 10 — 6 months, dose 1
Symptoms: Headaches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release